Mark Sweeney

Caroline Chatwin has written an extremely generous and insightful review of my 'Rethinking Drug Laws' book, published in the latest issue of @dhspolicy.bsky.social www.emerald.com/insight/cont...

County lines = a handy concept esp for journalists / news - it's so ambiguous it can mean whatever they want it to mean...

An analysis of intersectional disparities in alcohol consumption in the US Alcohol is one of the leading causes of preventable deaths in the United States (US). Prior research has demonstrated that alcohol consumption and rel…

New paper published in Social Science and Medicine 'An analysis of intersectional disparities in alcohol consumption in the US'. Led by @sophiebright.bsky.social, this study identifies several understudied groups who may have higher alcohol consumption than traditional methods would suggest.

Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms Stigma is a frequently cited barrier to help-seeking for many with substance-related conditions. Common ways of describing individuals with such probl…

Drug use researchers (esp. those in neuro/pharmacology) - please stop using the word "abuse" (e.g., drug abuse) and other stigmatizing terms

This isn't an arbitrary suggestion, there's legitimate empirical evidence showing that words like this do harm

www.sciencedirect.com/science/arti...

Our latest paper now available in HIV Medicine @bhiva.bsky.social examined mortality among people who inject drugs living with HIV in Scotland over a 20-year period and found increases over time, driven by a rise in drug-related deaths. OAT [again] was protective.

Hidden data on obesity prospect wipe $12B off Amgen market cap A hidden tab in an Excel spreadsheet published nine months ago has wiped $12 billion off Amgen’s market cap. | A hidden tab in an Excel spreadsheet published nine months ago has wiped $12 billion off ...

Be careful with hiding tabs in excel people - you might just end up wiping $12 billion off the value of your company... 😱
www.fiercebiotech.com/biotech/hidd...

Innovative trial will use psilocybin to target relapse in opioid addiction | Imperial News | Imperial College London Imperial researchers will explore the potential for psilocybin therapy in drug recovery as part of a landmark trial.

Exciting new study find if psilocybin could help people who have detoxed from opioids / heroin at Imperial College London. One of the largest studies of psychedelics in addiction to date.

www.imperial.ac.uk/news/257294/...